National Coverage Determinations

section notes

110 : Hematology/Immunology/Oncology

section notes
Document(s) Description
110.1  Hyperthermia for Treatment of Cancer
110.2  Certain Drugs Distributed by the National Cancer Institute
110.3  Anti-Inhibitor Coagulant Complex (AICC)
110.4  Extracorporeal Photopheresis
110.23  Stem Cell Transplantation Formerly 110.8.1
110.5  Granulocyte Transfusions
110.6  Scalp Hypothermia During Chemotherapy to Prevent Hair Loss
110.7  Blood Transfusions
110.8  Blood Platelet Transfusions
110.8.1  Stem Cell Transplantation
110.9  Antigens Prepared for Sublingual Administration
110.10  Intravenous Iron Therapy
110.11  Food Allergy Testing and Treatment
110.12  Challenge Ingestion Food Testing
110.13  Cytotoxic Food Tests
110.14  Apheresis (Therapeutic Pheresis)
110.15  Ultrafiltration, Hemoperfusion and Hemofiltration
110.16  Nonselective (Random) Transfusions and Living Related Donor Specific Transfusions (DST) in Kidney Transplantation
110.17  Anti-Cancer Chemotherapy for Colorectal Cancer
110.18  Aprepitant for Chemotherapy-Induced Emesis
110.19  Abarelix for the Treatment of Prostate Cancer
110.20  Blood Brain Barrier Osmotic Disruption for Treatment of Brain Tumors (Effective March 20, 2007)
110.21  Erythropoiesis Stimulating Agents (ESAs) in Cancer and Related Neoplastic Conditions
110.22  Autologous Cellular Immunotherapy Treatment
free demo
request yours today
pricing
for any budget
sign IN
welcome back!